N,N-dimethylglycine differentially modulates psychotomimetic and antidepressant-like effects of ketamine in mice-Reference-Cited by-同舟云学术

N,N-dimethylglycine differentially modulates psychotomimetic and antidepressant-like effects of ketamine in mice

Published:2016-11 Issue: Volume:71 Page:7-13
ISSN:0278-5846
Container-title:Progress in Neuro-Psychopharmacology and Biological Psychiatry
language:en
Short-container-title:Progress in Neuro-Psychopharmacology and Biological Psychiatry

Author:

Lin Jen-Cheng,Chan Ming-Huan,Lee Mei-Yi,Chen Yi-Chyan,Chen Hwei-Hsien

Funder

National Health Research Institutes

Ministry of Science and Technology

Publisher

Elsevier BV

Subject

Biological Psychiatry,Pharmacology

Reference57 articles.

1. Ketamine-induced changes in rat behaviour: a possible animal model of schizophrenia;Becker;Prog. Neuro-Psychopharmacol. Biol. Psychiatry,2003

2. GLYX-13, a NMDA receptor glycine-site functional partial agonist, induces antidepressant-like effects without ketamine-like side effects;Burgdorf;Neuropsychopharmacol. Off. Publ. Amer. College Neuropsychopharmacol.,2013

3. Ketamine as the prototype glutamatergic antidepressant: pharmacodynamic actions, and a systematic review and meta-analysis of efficacy;Caddy;Adv. Psychol.,2014

4. Effects of chronic ketamine use on frontal and medial temporal cognition;Chan;Addict. Behav.,2013

5. Inhibition of glycogen synthase kinase-3 attenuates psychotomimetic effects of ketamine;Chan;Schizophr. Res.,2012

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nuclear magnetic resonance spectroscopy reveals biomarkers of stroke recovery in a mouse model of obesity-associated type 2 diabetes;Bioscience Reports;2024-07

2. Targeted Analysis of Plasma Polar Metabolites in Postmenopausal Depression;Metabolites;2024-05-16

3. NMDA Receptor Antagonists: Emerging Insights into Molecular Mechanisms and Clinical Applications in Neurological Disorders;Pharmaceuticals;2024-05-15

4. Natural product Kaji-ichigoside F1 exhibits rapid antidepression via activating the AMPA–BDNF–mTOR pathway and inhibiting the NMDAR–CaMKIIα pathway;Phytomedicine;2024-04

5. Is the efficacy of oxytocin for autism diminished at higher dosages or repeated doses?: Potential mechanisms and candidate solutions;Peptides;2024-01